S

Researcher Profile

Shanade Dunn

1

Publications

33

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article Oncogene Oct 14, 2022

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors

Shanade Dunn · Cath Eberlein · Jason Yu · Albert Gris-Oliver +17 more

10.1038/s41388-022-02482-9 33 citations

Publication Timeline

2022

1

Frequent Co-Authors

Philip Hopcroft

Mathew J. Garnett

Anna Staniszewska

Natalie Cureton